JAKARTA Indonesia's largest pharmaceutical company, Kalbe Farma, is transforming itself from a maker of generic drugs to a high-tech pharma developer. Its two-year-old cancer drug plant has begun reaping results, and Kalbe is stepping up research and development of stem cell therapy products.



